IVL Completes Acquisition of Canada PTA Plant Enhances leadership in North American business

ข่าวทั่วไป Thursday June 4, 2015 14:46 —ThaiPR.net

กรุงเทพฯ--4 มิ.ย.--Indorama Ventures Indorama Ventures Public Company Limited (IVL), a world-leading producer of intermediate petrochemicals, has completed the deal that it had announced on 23 March 2015 to acquire 100% shareholding in the PTA business of CEPSA Chimie Montr้al s.e.c in Montreal, Canada from Cepsa Quํmica SA, wholly-owned affiliate of Cepsa, and IQ CHIMIE INC., a subsidiary of Investissement Qu้bec. The 600,000 tonne PTA plant will provide Indorama Ventures with feedstock security to better serve its customers and an enhanced leadership position in North America. “I heartily welcome our new colleagues at the Montreal PTA facility who complement our more than 14,000 employees worldwide. With the integration of the Canadian PTA facility, we now have all our global businesses present in North America and I believe this unique position is a win-win since we can now serve our customers more reliably and simultaneously to create accretive returns for our shareholders. Vertical integration into feedstocks has always been an important part of our global business strategy and we are now very excited to have finally completed the loop in our North American value chain,” said Mr. Aloke Lohia, Group CEO of Indorama Ventures Public Company Limited. “The PTA business in North America is robust and the timing of this acquisition comes with firmer margins and potentially firmer operating rates pending the results of the Anti-Dumping investigations on imported PET into USA. “North America is a large and attractive market where our business has expanded considerably over the years since our first entry in 2003. With multiple production assets in USA, Mexico and Canada, the company has become a leading player across PET, Fibers and High Value added products serving the safety and hygiene segments in the North American market.” Mr. Lohia concluded.
แท็ก INDORAMA VENTURES PUBLIC   (IVL)   WHO  

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ